The autophagy associated gene, ULK1, promotes tolerance to chronic and acute hypoxia

Radiotherapy and Oncology

Volumn 108, Issue 3, 2013, Pages 529-534

  Schaaf, Marco B E ^a   Cojocari, Dan ^b,c   Keulers, Tom G ^a   Jutten, Barry ^a   Starmans, Maud H ^a   De Jong, Monique C ^d   Begg, Adrian C ^d   Savelkouls, Kim G M ^a   Bussink, Johan ^e   Vooijs, Marc ^a   Wouters, Bradly G ^a,b,c,f   Rouschop, Kasper M A ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

Author keywords

Autophagy; Hypoxia; ULK1; UPR

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; MESSENGER RNA; REACTIVE OXYGEN METABOLITE;

ARTICLE; AUTOPHAGY; CANCER PROGNOSIS; CANCER RECURRENCE; FEMALE; GENE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GENE; ULK1 GENE; UNFOLDED PROTEIN RESPONSE; XENOGRAFT;

AUTOPHAGY; HYPOXIA; ULK1; UPR;

AUTOPHAGY; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; CELL LINE, TUMOR; CELL SURVIVAL; HEAD AND NECK NEOPLASMS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PROTEIN-SERINE-THREONINE KINASES; UNFOLDED PROTEIN RESPONSE;

EID: 84887018838     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.06.015     Document Type: Article

References (28)

1. S. Rademakers, I. Hoogsteen, and P. Rijken Pattern of CAIX expression is prognostic for outcome and predicts response to ARCON in patients with laryngeal cancer treated in a phase III randomized trial Radiother Oncol 108 2013 517 522
2. M. Nordsmark, S.M. Bentzen, and V. Rudat Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study Radiother Oncol 77 2005 18 24
3. M.W. Dewhirst, Y. Cao, and B. Moeller Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response Nat Rev Cancer 8 2008 425 437
4. T.G. Simonsen, J.V. Gaustad, M.N. Leinaas, and E.K. Rofstad Vascular abnormalities associated with acute hypoxia in human melanoma xenografts Radiother Oncol 105 2012 72 78
5. R.E. Durand, and C. Aquino-Parsons Clinical relevance of intermittent tumour blood flow Acta Oncol 40 2001 929 936
6. M.G. Magagnin, M. Koritzinsky, and B.G. Wouters Patterns of tumor oxygenation and their influence on the cellular hypoxic response and hypoxia-directed therapies Drug Resist Updat 9 2006 185 197
7. K. Toustrup, B.S. Sorensen, P. Lassen, C. Wiuf, J. Alsner, and J. Overgaard Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck Radiother Oncol 102 2012 122 129
8. X. Sun, L. Xing, and X. Deng Hypoxia targeted bifunctional suicide gene expression enhances radiotherapy in vitro and in vivo Radiother Oncol 105 2012 57 63
9. D. Ron, and P. Walter Signal integration in the endoplasmic reticulum unfolded protein response Nat Rev Mol Cell Biol 8 2007 519 529
10. K.M. Rouschop, T. van den Beucken, and L. Dubois The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5 J Clin Invest 120 2010 127 141
11. D.F. Egan, D.B. Shackelford, and M.M. Mihaylova Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy Science 331 2011 456 461
12. N. Hosokawa, T. Hara, and T. Kaizuka Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy Mol Biol Cell 20 2009 1981 1991
13. N. Mizushima The role of the Atg1/ULK1 complex in autophagy regulation Curr Opin Cell Biol 22 2010 132 139
14. M. Zhao, and D.J. Klionsky AMPK-dependent phosphorylation of ULK1 induces autophagy Cell Metab 13 2011 119 120
15. L.R. Pike, D.C. Singleton, and F. Buffa Transcriptional up-regulation of ULK1 by ATF4 contributes to cancer cell survival Biochem J 449 2013 389 400
16. K.M. Rouschop, C.H. Ramaekers, and M.B. Schaaf Autophagy is required during cycling hypoxia to lower production of reactive oxygen species Radiother Oncol 92 2009 411 416
17. H. Stegeman, J.H. Kaanders, and A.J. van der Kogel Predictive value of hypoxia, proliferation and tyrosine kinase receptors for EGFR-inhibition and radiotherapy sensitivity in head and neck cancer models Radiother Oncol 106 2013 383 389
18. K.I. Wijffels, J.H. Kaanders, and H.A. Marres Patterns of proliferation related to vasculature in human head-and-neck carcinomas before and after transplantation in nude mice Int J Radiat Oncol Biol Phys 51 2001 1346 1353
19. J. Pramana, M.W. Van den Brekel, and M.L. van Velthuysen Gene expression profiling to predict outcome after chemoradiation in head and neck cancer Int J Radiat Oncol Biol Phys 69 2007 1544 1552
20. C.H. Ramaekers, T. van den Beucken, and A. Meng Hypoxia disrupts the Fanconi anemia pathway and sensitizes cells to chemotherapy through regulation of UBE2T Radiother Oncol 101 2011 190 197
21. J. Theys, B. Jutten, and R. Habets E-cadherin loss associated with EMT promotes radioresistance in human tumor cells Radiother Oncol 99 2011 392 397
22. B.G. Wouters, T. van den Beucken, M.G. Magagnin, P. Lambin, and C. Koumenis Targeting hypoxia tolerance in cancer Drug Resist Updat 7 2004 25 40
23. M. Koritzinsky, K.M. Rouschop, and T. van den Beucken Phosphorylation of eIF2alpha is required for mRNA translation inhibition and survival during moderate hypoxia Radiother Oncol 83 2007 353 361
24. S. Pastorekova, Z. Zavadova, M. Kostal, O. Babusikova, and J. Zavada A novel quasi-viral agent, MaTu, is a two-component system Virology 187 1992 620 626
25. G.O. Janssens, S.E. Rademakers, and C.H. Terhaard Accelerated radiotherapy with carbogen and nicotinamide for laryngeal cancer: results of a phase III randomized trial J Clin Oncol 30 2012 1777 1783
26. S. Jiang, Y. Li, and Y.H. Zhu Intensive expression of UNC-51-like kinase 1 is a novel biomarker of poor prognosis in patients with esophageal squamous cell carcinoma Cancer Sci 102 2011 1568 1575
27. M.H. Starmans, K.C. Chu, and S. Haider The prognostic value of temporal in vitro and in vivo derived hypoxia gene-expression signatures in breast cancer Radiother Oncol 102 2012 436 443
28. K.M. Rouschop, L.J. Dubois, and T.G. Keulers PERK/eIF2alpha signaling protects therapy resistant hypoxic cells through induction of glutathione synthesis and protection against ROS Proc Natl Acad Sci USA 110 2013 4622 4627